276 related articles for article (PubMed ID: 25001848)
1. MHC class I and II deficiencies.
Hanna S; Etzioni A
J Allergy Clin Immunol; 2014 Aug; 134(2):269-75. PubMed ID: 25001848
[TBL] [Abstract][Full Text] [Related]
2. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
[TBL] [Abstract][Full Text] [Related]
3. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency.
Villard J; Lisowska-Grospierre B; van den Elsen P; Fischer A; Reith W; Mach B
N Engl J Med; 1997 Sep; 337(11):748-53. PubMed ID: 9287230
[TBL] [Abstract][Full Text] [Related]
4. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.
Villard J; Peretti M; Masternak K; Barras E; Caretti G; Mantovani R; Reith W
Mol Cell Biol; 2000 May; 20(10):3364-76. PubMed ID: 10779326
[TBL] [Abstract][Full Text] [Related]
5. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
Durand B; Sperisen P; Emery P; Barras E; Zufferey M; Mach B; Reith W
EMBO J; 1997 Mar; 16(5):1045-55. PubMed ID: 9118943
[TBL] [Abstract][Full Text] [Related]
6. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of the Bare lymphocyte syndrome.
Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Reith W
Rev Immunogenet; 2000; 2(2):267-82. PubMed ID: 11258423
[TBL] [Abstract][Full Text] [Related]
8. Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency.
Matheux F; Ikinciogullari A; Zapata DA; Barras E; Zufferey M; Dogu F; Regueiro JR; Reith W; Villard J
Mol Ther; 2002 Dec; 6(6):824-9. PubMed ID: 12498778
[TBL] [Abstract][Full Text] [Related]
9. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
[TBL] [Abstract][Full Text] [Related]
10. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.
Durand B; Kobr M; Reith W; Mach B
Mol Cell Biol; 1994 Oct; 14(10):6839-47. PubMed ID: 7935401
[TBL] [Abstract][Full Text] [Related]
11. [Research progress on regulation of class II MHC expression].
Sun QH; Peng JP
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):25-9. PubMed ID: 15127593
[TBL] [Abstract][Full Text] [Related]
12. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
[TBL] [Abstract][Full Text] [Related]
14. The bare lymphocyte syndrome and the regulation of MHC expression.
Reith W; Mach B
Annu Rev Immunol; 2001; 19():331-73. PubMed ID: 11244040
[TBL] [Abstract][Full Text] [Related]
15. A hierarchy of nuclear localization signals governs the import of the regulatory factor X complex subunits and MHC class II expression.
Nagarajan UM; Long AB; Harreman MT; Corbett AH; Boss JM
J Immunol; 2004 Jul; 173(1):410-9. PubMed ID: 15210800
[TBL] [Abstract][Full Text] [Related]
16. MHC class II deficiency: Report of a novel mutation and special review.
Farrokhi S; Shabani M; Aryan Z; Zoghi S; Krolo A; Boztug K; Rezaei N
Allergol Immunopathol (Madr); 2018; 46(3):263-275. PubMed ID: 28676232
[TBL] [Abstract][Full Text] [Related]
17. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene.
Peijnenburg A; Van Eggermond MC; Van den Berg R; Sanal O; Vossen JM; Van den Elsen PJ
Immunogenetics; 1999 Apr; 49(4):338-45. PubMed ID: 10079298
[TBL] [Abstract][Full Text] [Related]
19. Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B.
Wiszniewski W; Fondaneche MC; Lambert N; Masternak K; Picard C; Notarangelo L; Schwartz K; Bal J; Reith W; Alcaide C; de Saint Basile G; Fischer A; Lisowska-Grospierre B
Immunogenetics; 2000 Apr; 51(4-5):261-7. PubMed ID: 10803838
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.
Nekrep N; Jabrane-Ferrat N; Peterlin BM
Mol Cell Biol; 2000 Jun; 20(12):4455-61. PubMed ID: 10825209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]